Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $0.22 | Prev. Close $0.24 | Circuit Range N/A |
Day Range $0.22 - $0.23 | Year Range $0.05 - $2.41 | Volume 18,334 |
Average Traded $0.23 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $0.22 | $0.22 | +0.00% |
30-Apr-26 | $0.22 | $0.22 | +7.32% |
28-Apr-26 | $0.22 | $0.20 | -14.58% |
27-Apr-26 | $0.25 | $0.24 | +20.00% |
24-Apr-26 | $0.19 | $0.20 | -3.85% |
23-Apr-26 | $0.21 | $0.21 | -5.02% |
22-Apr-26 | $0.21 | $0.22 | +11.17% |